??-1 Receptor Ligands

Springer Science and Business Media LLC - Tập 18 Số 5 - Trang 269-284 - 2004
Teruo Hayashi1, Tsung‐Ping Su1
1Cellular Pathobiology Unit, Cellular Neurobiology Research Branch, Intramural Research Program, Department of Health and Human Services, National Institute on Drug Abuse, National Institutes of Health, 5500 Nathan Shock Drive, Baltimore, Maryland, 21209, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Martin, 1976, J Pharmacol Exp Ther, 197, 517

Haertzen, 1970, Psychopharmacologia, 18, 366, 10.1007/BF00402763

Brady, 1982, Science, 215, 178, 10.1126/science.6274022

Lahmeyer, 1980, Int J Addict, 15, 1219, 10.3109/10826088009040092

Blazer, 1975, Dis Nerv Syst, 36, 404

Yost Jr, 1970, Conn Med, 34, 259

Su, 1982, J Pharmacol Exp Ther, 223, 284

Vaupel, 1983, Eur J Pharmacol, 92, 269, 10.1016/0014-2999(83)90297-2

Quirion, 1992, Trends Pharmacol Sci, 13, 85, 10.1016/0165-6147(92)90030-A

Largent, 1986, J Pharmacol Exp Ther, 238, 739

Tam, 1985, Eur J Pharmacol, 109, 33, 10.1016/0014-2999(85)90536-9

Gundlach, 1986, J Neurosci, 6, 1757, 10.1523/JNEUROSCI.06-06-01757.1986

Largent, 1986, Eur J Pharmacol, 124, 183, 10.1016/0014-2999(86)90142-1

Bowen, 1989, Eur J Pharmacol, 163, 309, 10.1016/0014-2999(89)90200-8

Hanner, 1996, Proc Natl Acad Sci U S A, 93, 8072, 10.1073/pnas.93.15.8072

Seth, 1998, J Neurochem, 70, 922, 10.1046/j.1471-4159.1998.70030922.x

Seth, 1997, Biochem Biophys Res Commun, 241, 535, 10.1006/bbrc.1997.7840

Kekuda, 1996, Biochem Biophys Res Commun, 229, 553, 10.1006/bbrc.1996.1842

de Costa, 1989, FEBS Lett, 251, 53, 10.1016/0014-5793(89)81427-9

Narita, 1996, Eur J Pharmacol, 307, 117, 10.1016/0014-2999(96)00254-3

Shirayama, 1997, Eur J Pharmacol, 331, 319, 10.1016/S0014-2999(97)01051-0

ODell, 2000, Exp Clin Psychopharmacol, 8, 133, 10.1037/1064-1297.8.1.133

Sanchez, 1997, Psychopharmacology (Berl), 129, 197, 10.1007/s002130050181

Okuyama, 1996, CNS Drug Rev, 2, 226, 10.1111/j.1527-3458.1996.tb00299.x

Takahashi, 1999, Psychopharmacology (Berl), 145, 295, 10.1007/s002130051061

Borison, 1991, Psychopharmacol Bull, 27, 103

Gewirtz, 1994, Neuropsychopharmacology, 10, 37, 10.1038/npp.1994.5

Frieboes, 1997, Psychopharmacology (Berl), 132, 82, 10.1007/s002130050323

Muller, 1999, Psychiatry Res, 89, 275, 10.1016/S0165-1781(99)00100-6

Modell, 1996, Pharmacopsychiatry, 29, 63, 10.1055/s-2007-979546

Su, 1988, Science, 240, 219, 10.1126/science.2832949

Baulieu, 1998, Psychoneuroendocrinology, 23, 963, 10.1016/S0306-4530(98)00071-7

McCann, 1994, Synapse, 17, 182, 10.1002/syn.890170307

Stoffel-Wagner, 2001, Eur J Endocrinol, 145, 669, 10.1530/eje.0.1450669

Van Broekhoven, 2003, Psychopharmacology (Berl), 165, 97, 10.1007/s00213-002-1257-1

Uzunova, 1998, Proc Natl Acad Sci U S A, 95, 3239, 10.1073/pnas.95.6.3239

Bergeron, 1996, J Neurosci, 16, 1193, 10.1523/JNEUROSCI.16-03-01193.1996

Maurice, 1998, Neuroscience, 83, 413, 10.1016/S0306-4522(97)00405-3

Maurice, 1997, Behav Brain Res, 83, 159, 10.1016/S0166-4328(97)86061-5

Monnet, 1995, Proc Natl Acad Sci U S A, 92, 3774, 10.1073/pnas.92.9.3774

Bouchard, 1997, Neuroscience, 76, 467, 10.1016/S0306-4522(96)00221-7

Wolfe Jr, 1989, Endocrinology, 124, 1160, 10.1210/endo-124-3-1160

Graybiel, 1989, J Neurosci, 9, 326, 10.1523/JNEUROSCI.09-01-00326.1989

McCann, 1990, Eur J Pharmacol, 188, 211, 10.1016/0922-4106(90)90004-H

Inoue, 2000, Eur J Pharmacol, 401, 307, 10.1016/S0014-2999(00)00455-6

Hayashi, 2000, J Pharmacol Exp Ther, 293, 788

Phan, 2002, Eur J Neurosci, 15, 1523, 10.1046/j.1460-9568.2002.01989.x

Tsao, 1997, Synapse, 25, 117, 10.1002/(SICI)1098-2396(199702)25:2<117::AID-SYN2>3.0.CO;2-F

Ueda, 2001, J Pharmacol Exp Ther, 298, 703

Couture, 2001, Synapse, 39, 323, 10.1002/1098-2396(20010315)39:4<323::AID-SYN1016>3.0.CO;2-1

Hayashi, 2001, Proc Natl Acad Sci U S A, 98, 491, 10.1073/pnas.98.2.491

Hayashi, 2003, J Pharmacol Exp Ther, 306, 718, 10.1124/jpet.103.051284

Hayashi, 2003, J Pharmaco Exp Ther, 206, 726, 10.1124/jpet.103.051292

Aydar, 2002, Neuron, 34, 399, 10.1016/S0896-6273(02)00677-3

Karasawa, 2002, Life Sci, 70, 1631, 10.1016/S0024-3205(01)01549-1

Hayashi, 1999, Synapse, 31, 20, 10.1002/(SICI)1098-2396(199901)31:1<20::AID-SYN4>3.0.CO;2-2

Hayashi, 1995, J Pharmacol Exp Ther, 275, 207

Yamamoto, 1995, J Neurosci, 15, 731, 10.1523/JNEUROSCI.15-01-00731.1995

Church, 1985, Eur J Pharmacol, 111, 185, 10.1016/0014-2999(85)90755-1

Klette, 1997, Brain Res, 756, 231, 10.1016/S0006-8993(97)00142-X

Zhang, 2002, J Neurophysiol, 87, 2867, 10.1152/jn.2002.87.6.2867

Takebayashi, 2002, J Pharmacol Exp Ther, 303, 1227, 10.1124/jpet.102.041970

Ishihara, 2002, Nihon Shinkei Seishin Yakurigaku Zasshi, 22, 23

Monnet, 1990, Eur J Pharmacol, 179, 441, 10.1016/0014-2999(90)90186-A

Bermack, 2001, Br J Pharmacol, 134, 691, 10.1038/sj.bjp.0704294

Minabe, 1999, Synapse, 33, 129, 10.1002/(SICI)1098-2396(199908)33:2<129::AID-SYN3>3.0.CO;2-E

Earley, 1991, Brain Res, 546, 282, 10.1016/0006-8993(91)91492-J

Maurice, 1994, Pharmacol Biochem Behav, 49, 859, 10.1016/0091-3057(94)90235-6

Maurice, 1995, J Neural Transm Gen Sect, 102, 1, 10.1007/BF01276561

Maurice, 1996, Brain Res, 733, 219, 10.1016/0006-8993(96)00565-3

Reddy, 1998, Neuroreport, 9, 3069, 10.1097/00001756-199809140-00028

Urani, 2001, J Pharmacol Exp Ther, 298, 1269

Panocka, 2000, Pharmacol Biochem Behav, 66, 105, 10.1016/S0091-3057(00)00193-3

Tottori, 2001, Neuropharmacology, 41, 976, 10.1016/S0028-3908(01)00147-2

Yamada, 2000, Abs Soc Neurosci, 26, 2326

Kamei, 1997, Eur J Pharmacol, 319, 165, 10.1016/S0014-2999(96)00851-5

Gue, 1992, Br J Pharmacol, 107, 642, 10.1111/j.1476-5381.1992.tb14500.x

Gue, 1992, J Pharmacol Exp Ther, 261, 850

Takahashi, 2000, Neurosci Lett, 289, 21, 10.1016/S0304-3940(00)01258-1

Ujike, 1996, Eur J Pharmacol, 296, 123, 10.1016/0014-2999(95)00693-1

Ujike, 1992, Eur J Pharmacol, 211, 323, 10.1016/0014-2999(92)90388-K

Romieu, 2002, Neuropsychopharmacology, 26, 444, 10.1016/S0893-133X(01)00391-8

Matsumoto, 2000, Eur J Pharmacol, 401, 155, 10.1016/S0014-2999(00)00430-1

McCracken, 1999, Eur J Pharmacol, 370, 225, 10.1016/S0014-2999(99)00113-2

Matsumoto, 2002, Neuropharmacology, 42, 1043, 10.1016/S0028-3908(02)00056-4

Matsumoto, 2001, Eur J Pharmacol, 411, 261, 10.1016/S0014-2999(00)00917-1

Chien, 1994, J Pharmacol Exp Ther, 271, 1583

King, 1997, Eur J Pharmacol, 331, R5, 10.1016/S0014-2999(97)01064-9

Mei, 2002, J Pharmacol Exp Ther, 300, 1070, 10.1124/jpet.300.3.1070

Nestler, 2002, Neuron, 34, 13, 10.1016/S0896-6273(02)00653-0

Takahashi, 2001, Eur J Pharmacol, 427, 211, 10.1016/S0014-2999(01)01254-7

Ault, 1999, Eur J Pharmacol, 386, 145, 10.1016/S0014-2999(99)00769-4

Nuwayhid, 2003, J Pharmacol Exp Ther, 304, 364, 10.1124/jpet.102.043398

Kobayashi, 1996, J Pharmacol Exp Ther, 279, 106

Su, 2003, Curr Opin Med Chem, 10, 2073, 10.2174/0929867033456783

Wheal, 1998, Prog Neurobiol, 55, 611, 10.1016/S0301-0082(98)00026-4

Su, 2001, Trends Pharmacol Sci, 22, 456, 10.1016/S0165-6147(00)01740-5

Brown, 1988, Science, 242, 724, 10.1126/science.2903551

Deutsch, 1971, Science, 174, 788, 10.1126/science.174.4011.788

Matsuno, 1994, Eur J Pharmacol, 261, 43, 10.1016/0014-2999(94)90298-4

Maurice, 1997, Prog Neuropsychopharmacol Biol Psychiatry, 21, 69, 10.1016/S0278-5846(96)00160-1

Urani, 2002, Psychopharmacology (Berl), 163, 26, 10.1007/s00213-002-1150-y

Baulieu, 2001, Int Rev Neurobiol, 46, 1, 10.1016/S0074-7742(01)46057-0

Schumacher, 2003, Prog Neurobiol, 71, 3, 10.1016/j.pneurobio.2003.09.004

Jansen, 1993, Brain Res, 623, 299, 10.1016/0006-8993(93)91441-T

Jacobs, 1998, Neurology, 50, 368, 10.1212/WNL.50.2.368

Phillips, 1992, Psychoneuroendocrinology, 17, 485, 10.1016/0306-4530(92)90007-T

Morales, 1994, J Clin Endocrinol Metab, 78, 1360

Maurice, 2001, Brain Res Brain Res Rev, 37, 116, 10.1016/S0165-0173(01)00112-6

Raffa, 1998, Life Sci, 62, PL265, 10.1016/S0024-3205(98)00085-X

Bennett Jr, 1998, Ann Pharmacother, 32, 1201, 10.1345/aph.18026

Tamminga, 1998, Crit Rev Neurobiol, 12, 21, 10.1615/CritRevNeurobiol.v12.i1-2.20

Matthews, 1986, J Pharmacol Exp Ther, 239, 124

Jentsch, 1999, Neuropsychopharmacology, 20, 201, 10.1016/S0893-133X(98)00060-8

Walker, 1988, Neurology, 38, 961, 10.1212/WNL.38.6.961

Sharkey, 1988, Eur J Pharmacol, 149, 171, 10.1016/0014-2999(88)90058-1

Shibuya, 1992, Neurochem Res, 17, 983, 10.1007/BF00966825

Helmeste, 1996, Eur J Pharmacol, 314, R3, 10.1016/S0014-2999(96)00702-9

Ohmori, 2000, Am J Med Genet, 96, 118, 10.1002/(SICI)1096-8628(20000207)96:1<118::AID-AJMG23>3.0.CO;2-C

Ishiguro, 1998, Neurosci Lett, 257, 45, 10.1016/S0304-3940(98)00797-6

Schwarcz, 1985, Drug Dev Res, 5, 387, 10.1002/ddr.430050412

Grunder, 1999, Psychopharmacology (Berl), 146, 81, 10.1007/s002130051091

Akiyama, 1994, Schizophr Res, 12, 251, 10.1016/0920-9964(94)90035-3

Girdler, 2001, Biol Psychiatry, 49, 788, 10.1016/S0006-3223(00)01044-1

Strous, 2001, Int J Neuropsychopharmacol, 4, 259, 10.1017/S1461145701002462

Osran, 1993, Am J Psychiatry, 150, 806, 10.1176/ajp.150.5.806

Browne, 1992, Am J Med Sci, 303, 366, 10.1097/00000441-199206000-00003

Wolkowitz, 1997, Biol Psychiatry, 41, 311, 10.1016/S0006-3223(96)00043-1

Kolb, 2003, Proc Natl Acad Sci U S A, 100, 10523, 10.1073/pnas.1834271100

Robinson, 2001, Synapse, 39, 257, 10.1002/1098-2396(20010301)39:3<257::AID-SYN1007>3.0.CO;2-1

Manji, 2001, Nat Med, 7, 541, 10.1038/87865